GLP-1 secretion-promoting composition

JP2025168012APending Publication Date: 2025-11-07MEIJI UNIV +1
1 Cites 0 Cited by

Patent Information

Application Number
JP2024073100
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-04-26
Publication Date
2025-11-07

AI Technical Summary

Technical Problem

There is a need for an ingredient that can promote GLP-1 secretion, which is commonly consumed as food, and also addresses various health benefits such as insulin secretion, glucose control, and obesity management.

Method used

A composition comprising acylglycerols with palmitic or myristic acid bound to the β-position, which can be used to promote GLP-1 secretion and activate GPR40 and GPR119 receptors, thereby enhancing insulin secretion, suppressing glucagon secretion, and providing other health benefits.

Benefits of technology

The composition effectively promotes GLP-1 secretion, contributing to health maintenance in individuals with nutritional challenges and infants, and offers benefits like insulin secretion enhancement, diabetes treatment, and appetite suppression.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2025168012000001_ABST
    Figure 2025168012000001_ABST
Patent Text Reader

Abstract

To provide a component that enables promotion of GLP-1 secretion and to clarify a new function of a component with a history of dietary use.SOLUTION: Provided is a GLP-1 secretion-promoting composition containing, as an active ingredient, an acylglycerol in which palmitic acid or myristic acid is bound at the β-position, preferably a monoglyceride in which palmitic acid is bound at the β-position.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • GIP increase inhibitor

    JP2016047805A